# Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure

> **NCT06038682** · — · COMPLETED · sponsor: **University Hospital Ostrava** · enrollment: 100 (actual)

## Conditions studied

- ARDS
- COVID-19

## Interventions

- **DRUG:** Argatroban Injection
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT06038682
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06038682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06038682, "Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06038682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*